Failure of the uterus or our understanding?
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. On 15 January 2024, a new fact will enter the world. It will take …
The WOMAN Trials in 2023: a year in quotes
As 2023 draws to a close, we reflect on what a year it has been for the WOMAN Trials. Below some of the team give their thoughts on what have …
Tackling anaemia could be crucial in minimising postpartum haemorrhage, new study suggests
A paper published today in the Journal of Thrombosis and Haemostasis from authors based at Semmelweis University in Hungary and the London School of Hygiene & Tropical Medicine (LSHTM) shows …
Prevent, detect and treat anaemia for safer childbirth
Worldwide, half a billion women are anaemic. This video shows how anaemia affects the blood, causing it to clot less and flow faster, which can increase the risk of excessive …
WHO releases roadmap to combat postpartum haemorrhage
The World Health Organization (WHO) has released its first roadmap to tackle excessive bleeding after childbirth known as postpartum haemorrhage (PPH). PPH affects millions of women annually and is the …
Podcast: In conversation with Rizwana Chaudhri and Ian Roberts
Professor Rizwana Chaudhri and Professor Ian Roberts speak with The Lancet Global Health about research carried out by the WOMAN Trials collaborators investigating the link between maternal anaemia and postpartum haemorrhage.
Explainer video: How maternal anaemia causes severe bleeding in childbirth
Evidence from the WOMAN-2 Trial shows that pregnant women with anaemia are substantially more likely to suffer life-threatening bleeding after childbirth. This video shows how anaemia can increase risk of …
Comment: Structural racism and iron deficiency anaemia
Professor Ian Roberts and Professor Camara Phyllis Jones comment in The Lancet on the link between postpartum haemorrhage, iron deficiency anaemia and structural racism.
Severe anaemia linked to seven-fold increased risk of death or life-threatening bleeding after childbirth
The WOMAN-2 Trial found that a reduction in haemoglobin of 10 grams per litre of blood just before birth increased the risk of life threatening bleeding after childbirth by 23%.
International Clinical Trials Day: Q&A with Haleema Shakur-Still
Haleema Shakur-Still is Emeritus Professor of Global Health Clinical Trials at the London School of Hygiene & Tropical Medicine and Co-Principal Investigator of the WOMAN-2 Trial.